Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intel
INTC
$466B
| $563M | 0.31% |
10,930,758
+1,735,487
| +19% | +$85.3M |
|
77
Johnson & Johnson
JNJ
$635B
| $560M | 0.3% |
4,331,666
+344,635
| +9% | +$45.4M |
|
78
LyondellBasell Industries
LYB
$19.5B
| $557M | 0.3% |
6,221,336
+343,792
| +6% | +$28M |
|
79
IQVIA
IQV
$34.7B
| $553M | 0.3% |
3,700,180
+69,541
| +2% | +$10.8M |
|
80
Honeywell
HON
$77.1B
| $536M | 0.29% |
3,363,826
+351,658
| +12% | +$55.9M |
|
81
Revvity
RVTY
$12.3B
| $528M | 0.29% |
6,197,979
-70,118
| -1% | -$6.14M |
|
82
JPMorgan Chase
JPM
$939B
| $527M | 0.29% |
4,479,404
-273,737
| -6% | -$31M |
|
83
W.R. Berkley
WRB
$28B
| $518M | 0.28% |
16,145,773
+155,664
| +1% | +$4.86M |
|
84
Amdocs
DOX
$5.53B
| $512M | 0.28% |
7,738,712
+24,453
| +0.3% | +$1.57M |
|
85
Euronet Worldwide
EEFT
$3.02B
| $508M | 0.28% |
3,469,574
+155,221
| +5% | +$24M |
|
86
Deere & Co
DE
$170B
| $499M | 0.27% |
2,957,976
+176,809
| +6% | +$28.3M |
|
87
Cimpress
CMPR
$2.37B
| $498M | 0.27% |
3,780,948
-4,562
| -0.1% | -$502K |
|
|
88
Medtronic
MDT
$107B
| $497M | 0.27% |
+4,571,875
| New | +$477M |
|
89
Sensata Technologies
ST
$6.65B
| $496M | 0.27% |
9,909,768
-1,973,871
| -17% | -$93.3M |
|
90
Edwards Lifesciences
EW
$47.6B
| $494M | 0.27% |
6,745,701
-616,008
| -8% | -$43.3M |
|
91
Humana
HUM
$46.7B
| $492M | 0.27% |
1,923,063
-240,841
| -11% | -$67.5M |
|
92
Crown Holdings
CCK
$12.8B
| $475M | 0.26% |
7,182,987
+419,153
| +6% | +$26.9M |
|
|
DNKN
93
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $471M | 0.26% |
5,931,479
-426,476
| -7% | -$34.6M |
|
94
Constellation Brands
STZ
$22.2B
| $467M | 0.25% |
2,251,815
-111,550
| -5% | -$22.4M |
|
95
ICU Medical
ICUI
$3.93B
| $458M | 0.25% |
2,868,241
+42,405
| +2% | +$8.44M |
|
96
American Express
AXP
$223B
| $455M | 0.25% |
3,848,228
+573,304
| +18% | +$70.3M |
|
97
General Dynamics
GD
$105B
| $452M | 0.25% |
2,475,100
+139,141
| +6% | +$25.8M |
|
98
Hilton Worldwide
HLT
$74B
| $447M | 0.24% |
4,804,287
+215,986
| +5% | +$20.5M |
|
99
Elevance Health
ELV
$81.9B
| $446M | 0.24% |
1,857,524
-331,988
| -15% | -$91M |
|
100
Blackbaud
BLKB
$1.5B
| $441M | 0.24% |
4,882,552
+3,646
| +0.1% | +$324K |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.